| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $794.8M | +14.1% |
| Cost of Revenue | $365.1M | +6.8% |
| Gross Profit | $429.7M | +21.2% |
| R&D Expense | $154.3M | +7.7% |
| SG&A Expense | $125.5M | +2.1% |
| Operating Income | $39.9M | +194.4% |
| Interest Expense | $2.8M | +5.0% |
| Pre-tax Income | $54.7M | +277.3% |
| Income Tax | $2.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $367.6M | +2.5% |
| Short-term Investments | $65.1M | -26.1% |
| Accounts Receivable | $51.7M | +22.9% |
| Current Assets | $556.1M | -0.5% |
| Total Assets | $1.28B | -1.4% |
| Current Liabilities | $544.1M | +36.4% |
| Total Liabilities | $614.5M | -20.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $201.5M | +48.4% |
| Capital Expenditures | $6.8M | +1.8% |
| Investing Cash Flow | -$4.0M | +80.9% |
| Financing Cash Flow | -$189.0M | -1519.0% |
| Free Cash Flow | $194.7M | +50.8% |
| -64.6% |
| Net Income | $52.0M | +235.0% |
| EPS (Basic) | $0.84 | +231.3% |
| EPS (Diluted) | $0.80 | +225.0% |
| Stockholders' Equity |
| $661.8M |
| +27.8% |